Page results
-
Advice on relaxation techniques for young people living with fatigue conditions.
-
All HPB and hepatology clinical and academic services, including pancreatic cancer services, have transferred from UCLH to the Royal Free Hampstead NHS Trust, creating one of the largest centres in Europe for the treatment of conditions of the liver, pancreas and biliary system.
-
Advice on managing education for young people living with fatigue conditions.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
-
This service is unique in the UK, offering an adolescent rheumatology service that provides diagnostic and therapeutic advice to patients with any rheumatic diseases that occur in adolescence.
-
Tattoos and cosmetic procedures
-
This page provides information about endovascular treatments which use a trans-venous approach in the NHNN angiography suite.
-
Advice on managing flare-ups and relapses for young people living with fatigue conditions.
-
Information about the Integrated Cancer Care Service at UCLH
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
File results
-
FOI/2022/0169 - Strategic workforce plan for recruitment and retention of Allied Health Professions
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients